$PFE

Schwab Network on $PFE (Sep 2, 2026)

AI summary · Schwab Network

PFE is a buy; downside protected by 6% yield and priced-in bad news, upside from oncology and GLP-1 pipeline.

Bullish
“Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities”
Schwab NetworkPublished Sep 2 · 1 passage

Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy

Jump to any passage

1 passage

I love it because it's so out of favor you can't give the stock away. Um you're getting a 6% dividend yield while you wait for them to turn the boat. They had a COVID windfall.

They used the money to buy CGEN 43 billion. That's going to do10 billion dollars a year. They cut 7.2 billion in cost. People are afraid of the loss of exclusivity from some of their major drugs.

It's lower than expected. And they have a GLP1 with the Metera coming out uh 2728, which is once a month GLP uh which you can take as a pill and subcutaneous. So maybe they'll be late to the party, maybe it'll be revolutionary.

We don't know. But in the meantime, costs are out. The oncology franchise pipeline is robust. All the bad news is priced in. You you got you're you know, I learned early on in this business, if your downside is protected, your upside will take care of itself.

And if I'm paid 6% to wait while this thing, you know, uh recovers over time. That's a good thing, not a bad thing.

Watchpoints

GLP-1 drug launch (Metera)

What this channel has said about $PFE

Schwab Network has 2 calls on this stock; only the adjacent ones are shown.

TickerSays